Welcome to our dedicated page for NeueHealth news (Ticker: BHG), a resource for investors and traders seeking the latest updates and insights on NeueHealth stock.
NeueHealth, Inc. (BHG) drives innovation in value-based care through integrated health solutions and digital-first insurance models. This news hub provides investors and industry stakeholders with timely updates on the company’s strategic initiatives, operational milestones, and healthcare technology advancements.
Access official press releases and curated analysis covering NeueHealth’s partnerships with health systems, product developments, and regulatory engagements. Our repository simplifies tracking of earnings announcements, leadership updates, and emerging trends in connected care ecosystems.
Discover how BHG’s subscription-based insurance models and patient engagement tools evolve through verified updates. Bookmark this page for efficient monitoring of NeueHealth’s progress in bridging healthcare accessibility gaps via technology-driven solutions.
Bright Health Group (NYSE: BHG) has announced it will report its First Quarter financial results on May 9, 2023, before the markets open, followed by a conference call at 8:00 AM Eastern Time. The company focuses on providing value-driven healthcare to aging and underserved consumers through its Fully Aligned Care Model in major markets including Florida, Texas, and California.
Participants can join the call by pre-registering via a provided link, and a webcast will also be available on the company’s Investor Relations page. Bright Health Group is dedicated to making healthcare accessible and affordable, aiming to address the needs of 26% of the aging U.S. population.
Bright Health Group, Inc. (BHG) reported Q4 2022 revenue of $551.4 million, with a net loss of $188.2 million. For the full year 2022, revenue totaled $2.4 billion, with a net loss of $638 million. The company aims for adjusted EBITDA profitability in 2023, despite lowering revenue expectations due to finalized accounting for value-based care contracts. Bright Health reported over $150 million in cash as of February 24, 2023, but breached liquidity covenants, requiring amendments to its credit agreements. Key metrics show growth in commercial and Medicare Advantage consumers, indicating a focus on value-driven care.
Bright Health Group, Inc. (NYSE: BHG) will report its Fourth Quarter financial results on March 1, 2023, before market opening. A conference call is scheduled for 8:00 AM Eastern Time on the same day, with pre-registration available for telephone participants. The company focuses on providing technology-enabled, value-driven healthcare for aging and underserved consumers through its Fully Aligned Care Model, primarily in Florida, Texas, and California, which together represent a significant portion of the U.S. aging population. Investors can access the earnings call via Bright Health's Investor Relations page.
Bright Health Group (NYSE: BHG) has increased its 2023 enterprise revenue guidance to
Bright Health Group (NYSE: BHG) announced that CEO Mike Mikan will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, starting at 6:00 p.m. ET in San Francisco, CA. The event will be available via live webcast, with a replay accessible on Bright Health’s Investor Relations page afterwards. Bright Health is dedicated to serving aging and underserved consumers, focusing on unmet clinical needs through a technology-enabled, value-based healthcare model in key markets such as Florida, Texas, and California.
Bright Health Group (NYSE: BHG) received a notice from the NYSE indicating non-compliance with listing standards due to its stock price being below $1.00 over a consecutive 30-day period ending December 2, 2022. The Company has a six-month period to regain compliance, during which its stock will continue to trade. Options include a potential reverse stock split pending stockholder approval. Non-compliance does not affect ongoing operations or SEC reporting requirements, but failure to meet the minimum price may lead to delisting procedures.
NeueHealth Partners Community ACO has been provisionally accepted into the ACO REACH model, starting January 1, 2023. This initiative, a collaboration between NeueHealth and Medical Home Network, aims to support Federally Qualified Health Centers in transitioning to value-based care. The ACO will serve approximately 20,000 Medicare beneficiaries across Missouri, Ohio, Michigan, and Indiana. The model focuses on improving care coordination and advancing health equity for underserved communities, leveraging MHN's proven care management strategies.
Bright Health Group reported a Q3 2022 revenue of $1.6 billion, a 51.3% increase from Q3 2021. Despite a GAAP net loss of $259.4 million, the company improved its Enterprise Medical Cost Ratio to 90.6%, down from 103.0% the previous year. Adjusted EBITDA loss was $82.9 million. The company revised its 2022 guidance, reducing the expected cost ratio to 90%-92% and adjusting EBITDA loss to $550-$700 million. Bright Health Group aims for Adjusted EBITDA profitability in 2023.
Bright Health Group, Inc. (NYSE: BHG) will report its Third Quarter financial results on November 9, 2022, before markets open, followed by a conference call at 8:00 AM Eastern Time. Investors can join the call by pre-registering for access details. Bright Health focuses on managing population risk through its technology-enabled, value-based healthcare model, serving underserved consumers in Florida, Texas, and California, which house a significant portion of the U.S. aging population.
